Your browser doesn't support javascript.
loading
Single-dose pharmacokinetics, safety, and tolerability of modified-release formulations of lersivirine in healthy subjects.
Vourvahis, Manoli; Wang, Ronnie; Mendes da Costa, Laure; Wang, Cunshan; Weatherley, Barry; Mukwaya, Geoffrey; Tawadrous, Margaret; Heera, Jayvant.
Affiliation
  • Vourvahis M; Pfizer Global Research and Development, New York, NY, USA.
  • Wang R; Pfizer Global Research and Development, Groton, CT, USA.
  • Mendes da Costa L; Pfizer Clinical Research Unit, Brussels, Belgium.
  • Wang C; Pfizer Global Research and Development, Groton, CT, USA.
  • Weatherley B; Pfizer Global Research and Development, Sandwich, Kent, UK.
  • Mukwaya G; Pfizer Global Research and Development, New York, NY, USA.
  • Tawadrous M; Pfizer Global Research and Development, Groton, CT, USA.
  • Heera J; Pfizer Global Research and Development, Groton, CT, USA.
Clin Pharmacol Drug Dev ; 3(6): 472-6, 2014 Nov.
Article in En | MEDLINE | ID: mdl-27129121
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Clin Pharmacol Drug Dev Year: 2014 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Clin Pharmacol Drug Dev Year: 2014 Document type: Article Affiliation country: United States Country of publication: United States